Richard Mountfield

General Counsel at CONSTELLATION PHARMACEUTICALS, INC.

Health Technology

Consumer Services

Commercial Services

Profile

Richard Mountfield is currently the Senior Vice President-Regulatory Affairs & Quality at Constellation Pharmaceuticals, Inc. and the SVP-Regulatory Affairs & Quality at Aura Biosciences, Inc. Previously, he held positions as the VP-Global Regulatory Affairs at Celyad Oncology SA and the Senior VP-Regulatory Affairs & Drug Development at Boston Pharmaceuticals, Inc. Dr. Mountfield obtained a doctorate degree from the University of Aberystwyth.

Richard Mountfield active positions

Companies	Position	Start
CONSTELLATION PHARMACEUTICALS, INC.	General Counsel	-
AURA BIOSCIENCES, INC.	General Counsel	-

All active positions of Richard Mountfield

Former positions of Richard Mountfield

Companies	Position	End
Boston Pharmaceuticals, Inc. Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA.	General Counsel	-
CELYAD ONCOLOGY SA	General Counsel	-

See the detail of Richard Mountfield's experience

Training of Richard Mountfield

University of Aberystwyth

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Richard Mountfield's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
AURA BIOSCIENCES, INC.	Health Technology
CELYAD ONCOLOGY SA	Health Technology

Private companies	2
Constellation Pharmaceuticals, Inc. Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA.	Health Technology
Boston Pharmaceuticals, Inc. Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA.	Commercial Services

Private companies